Patients with LS also have an increased risk of developing extra-colon cancers such as endometrial, ovarian, stomach, and small intestine cancers, especially if they have mutations in the MLH1, MSH2, and MSH6 genes. This evidence concerns the gene MSH2 and Leigh syndrome.